05:57:47 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-08 Kvartalsrapport 2024-Q3
2024-08-23 Kvartalsrapport 2024-Q2
2024-05-14 Kvartalsrapport 2024-Q1
2024-04-29 Ordinarie utdelning OMDA 0.48 NOK
2024-04-25 Årsstämma 2024
2024-03-01 Bokslutskommuniké 2023
2023-11-10 Kvartalsrapport 2023-Q3
2023-09-26 Extra Bolagsstämma 2023
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-12 Kvartalsrapport 2023-Q1
2023-04-28 Ordinarie utdelning OMDA 0.00 NOK
2023-04-27 Årsstämma 2023
2023-02-28 Bokslutskommuniké 2022
2022-11-30 Kvartalsrapport 2022-Q3
2022-10-03 Extra Bolagsstämma 2022
2022-08-30 Kvartalsrapport 2022-Q2
2022-05-20 Ordinarie utdelning OMDA 0.00 NOK
2022-05-19 Kvartalsrapport 2022-Q1
2022-05-19 Årsstämma 2022
2022-02-25 Bokslutskommuniké 2021
2021-11-26 Kvartalsrapport 2021-Q3
2021-08-31 Kvartalsrapport 2021-Q2
2021-05-26 Kvartalsrapport 2021-Q1
2021-05-07 Ordinarie utdelning OMDA 0.00 NOK
2021-05-06 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-12-11 Extra Bolagsstämma 2020
2020-11-27 Kvartalsrapport 2020-Q3

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorInformationsteknik
IndustriProgramvara
OMDA är verksamma inom teknikbranschen. Bolaget är specialiserade inom utveckling av digitala plattformar för vården. Programvaran är egenutvecklad och används huvudsakligen för analys och uppföljning av olika områden inom sjukvården. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Verksamhet innehas på global nivå med störst närvaro inom den europeiska marknaden.
2020-12-18 20:49:54
Oslo, Norway, December 18, 2020: CSAM Health Group AS ("CSAM"), the leading
provider of niche eHealth solutions in the Nordics, today announced that they
have entered into a Share Purchase Agreement for the acquisition of all shares
in Fertsoft AB ("Fertsoft").

With the acquisition of Fertsoft, CSAM has created a comprehensive portfolio of
women and children's healthcare solutions - ranging from conception to early
childhood - and further strengthened its position.

Fertsoft, founded in 2010, provides complete care and practice management
software for Assisted Reproductive Technology (ART) clinics. The company is
headquartered in Uppsala, Sweden and serves customers across the Nordics and
Europe.

- The acquisition of Fertsoft allows CSAM to expand our already leading
portfolio of solutions in women and children's health, adding our first-ever
software solutions within the growing ART market, said Sverre Flatby, CSAM CEO.

- Fertsoft and CSAM share a commitment to enabling excellent care through the
delivery of highly specialised eHealth solutions, said Martin Björkman, Chief
Developer and CEO of Fertsoft. - I am confident that Fertsoft will find a great
home at CSAM, allowing us to grow our reach to new customers and markets, and
ultimately helping more people realise their dream of having a child.

Fertsoft reported annual sales of ca 4.8 MSEK for its deviating accounting year
that ended June 30, 2020. The agreed purchase price is 6 MSEK, and will be
settled through an issue of shares in CSAM Health Group AS.

The transaction is expected to close later this month.

For more information, contact:

Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM

CSAM has established itself as a leading Nordic niche player in the specialised
eHealth market with a unique blend of best-in-class innovative technology, and
outstanding human skills. The company's diverse portfolio of software solutions
enables healthcare providers to access relevant clinical information at the
point of care. CSAM's commercial headquarters are located in Oslo, Norway. The
company also has local offices in Stockholm, Karlstad, Gothenburg, Copenhagen,
Helsinki, Oulu, Tampere, Tromsø and Warwickshire, as well as a wholly owned
software engineering subsidiary in the Philippines.

For more information, visit www.csamhealth.com.